check_circleStudy Completed
Hypertension
Bayer Identifier:
14296
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Treatment of hypertension with Adalat® in combination with other drugs
Trial purpose
To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
4497Trial Dates
January 2010 - September 2011Phase
N/ACould I Receive a placebo
NoProducts
Adalat CC (Nifedipine, BAYA1040)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Russia | |
Completed | Many Locations, Pakistan | |
Completed | Many Locations, Egypt | |
Terminated | Many Locations, Morocco | |
Completed | Many Locations, Saudi Arabia | |
Completed | Many Locations, Bahrain | |
Completed | Many Locations, United Arab Emirates | |
Completed | Many Locations, Oman | |
Completed | Many Locations, Jordan | |
Completed | Many Locations, Lebanon | |
Completed | Many Locations, Qatar |
Primary Outcome
- Evaluation of treatment success (lowering of blood pressure in mmHg) in adult hypertensive patientsdate_rangeTime Frame:After three monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A